Ophthalmic Consultants of Boston
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1969-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.drraizman.com
YAG Vitreolysis for Floaters
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-09-13
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- Ophthalmic Consultants of Boston
- Target Recruit Count
- 52
- Registration Number
- NCT02897583
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-11-09
- Last Posted Date
- 2015-05-22
- Lead Sponsor
- Ophthalmic Consultants of Boston
- Target Recruit Count
- 24
- Registration Number
- NCT01724554
- Locations
- 🇺🇸
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
Phase 1
- Conditions
- First Posted Date
- 2007-06-25
- Last Posted Date
- 2007-06-25
- Lead Sponsor
- Ophthalmic Consultants of Boston
- Target Recruit Count
- 10
- Registration Number
- NCT00491166
- Locations
- 🇺🇸
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
- First Posted Date
- 2006-11-03
- Last Posted Date
- 2010-01-08
- Lead Sponsor
- Ophthalmic Consultants of Boston
- Target Recruit Count
- 30
- Registration Number
- NCT00395551
Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose
Phase 4
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2006-07-04
- Lead Sponsor
- Ophthalmic Consultants of Boston
- Target Recruit Count
- 40
- Registration Number
- NCT00347828
- Locations
- 🇺🇸
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
© Copyright 2024. All Rights Reserved by MedPath